Rathbones Group’s Accendra Health ACH Stock Holding History

Rathbones Group’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,250	Closed	-$34.8K	–	689
2026 Q1	$34.8K	Buy	+15,250	New	+$35.1K	﹤0.01%	639

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rathbones Group's ACH Position: Q2 2026 in Review

Rathbones Group sold out of Accendra Health (ACH) in Q2 2026, closing a stake of 15,250 shares — an estimated $34.8K sold.

Rathbones Group first reported a position in ACH in Q1 2026 and held it in 1 quarter. The position peaked at $34.8K in Q1 2026. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

Rathbones Group reported no remaining Accendra Health position as of Q2 2026 after selling out during the quarter.
Rathbones Group sold 15,250 Accendra Health shares in Q2 2026, an estimated $34.8K.
Rathbones Group first reported a position in Accendra Health in Q1 2026 and held it in 1 quarter.
Rathbones Group's Accendra Health position peaked at $34.8K in Q1 2026.
139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.